Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Assessment of the prognostic value of FDG PET-derived markers and responses in POLARIX

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAnne‐Ségolène CottereauLCLoïc ChartierCBConnie Lee Batlevi

Discussion

Loading...

Member takes

Overview

Analysis reveals metabolic response and cell-of-origin impact prognosis in DLBCL, suggesting implications for therapy optimization.

Key Points

  • High baseline metabolic response predicts patient outcomes in DLBCL, indicating its relevance across treatment arms.
  • Kaplan-Meier method highlighted differences in 5-year survival rates and response stratification based on DLBCL characteristics.
  • Assessments using FDG-PET metrics confirmed the prognostic value of metabolic indicators in treatment efficacy for DLBCL.
  • Findings underscore the importance of metabolic response EOT in predicting long-term outcomes for DLBCL patients.

Cite This Study

Cottereau et al. (2025) studied this question.

synapsesocial.com/papers/69362f5a4fa91c937236db0ahttps://doi.org/10.1182/blood-2025-5329
View Full Paper
Ask AI
Bookmark
Share